Status:
COMPLETED
Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis
Lead Sponsor:
University of Michigan
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
10-21 years
Phase:
NA
Brief Summary
The investigators know that adherence to medications in children with cystic fibrosis (CF) is poor. Forgetfulness has often been reported as a barrier to adherence by both CF patients and their parent...
Detailed Description
This is a randomized controlled trial to assess the impact of home lung function monitoring and medication reminders on adherence, clinical outcomes and quality of life in children with cystic fibrosi...
Eligibility Criteria
Inclusion
- Age 10-21 years
- Confirmed diagnosis of cystic fibrosis (CF) either by a sweat chloride ≥ 60mEq/L or the presence of two disease-causing mutations
- Patients must be clinically stable with at least 1 month from their last hospitalization or use of oral antibiotics for a pulmonary exacerbation
- Signed informed consent from the patient and/or from the parent/legal guardian, if younger than 18 years.
Exclusion
- Age less than 10 years or greater than 21 years
- Clinically unstable
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT02301377
Start Date
November 1 2014
End Date
March 1 2015
Last Update
July 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109